Rheumatoid Arthritis Cure: Is There Such A Thing?

Merck Medical Research Boceprevir achieved SVR rate significantly higher in the treatment of non-treatment and Merck announced today … the final results of two pivotal phase III studies of boceprevir, its oral protease inhibitor against experimental hepatitis C showed significantly higher sustained virologic response rates in an adult patients who have failed treatment of adult [...]